NASDAQ:BBNX | Free Cash Flow | Beta Bionics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2023-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$23.83M$1.38M-$25.21M
2025-12-31-$8.63M$1.9M-$10.53M
2025-03-31-$19.98M$333,000.00-$20.31M
2024-12-31-$14.28M$561,000.00-$14.84M
2024-03-31-$12.14M$406,000.00-$12.55M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$50.93M$5.3M-$56.22M
2024-12-31-$48.27M$3.4M-$51.67M
2023-12-31-$32.45M$402,000.00-$32.85M